Neuropace, Inc. · NASDAQ:NPCE
Soleus Capital Management, L.P. reported a 7.00% stake in Neuropace, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 5, 2025
Soleus Capital Management, L.P. reported a 7.00% stake in Neuropace, Inc., 2,303,828 shares, as a passive investor on Jun 30, 2025. Filed Aug 5, 2025 (Schedule 13G/A).
- Stake
- 7.00%
- Shares
- 2,303,828
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Private Equity Fund I, L.P. | 0.90% | 310,321 |
| Soleus Private Equity GP I, LLC | 0.90% | 310,321 |
| Soleus PE GP I, LLC | 0.90% | 310,321 |
| Soleus Capital Master Fund, L.P. | 6.10% | 1,993,507 |
| Soleus Capital, LLC | 6.10% | 1,993,507 |
| Soleus Capital Group, LLC | 6.10% | 1,993,507 |
| Soleus Capital Management, L.P. | 7.00% | 2,303,828 |
| Soleus GP, LLC | 7.00% | 2,303,828 |
| Guy Levy | 7.00% | 2,303,828 |